Research analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of NASDAQ:SRNE opened at $0.01 on Monday. Sorrento Therapeutics has a 12 month low of $0.00 and a 12 month high of $0.25. The company’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.02.
Sorrento Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- How is Compound Interest Calculated?
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- When to Sell a Stock for Profit or Loss
- Lowe’s Stock: Hold Now, Buy it When it Dips
- What Are Dividend Achievers? An Introduction
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.